The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm
- PMID: 35177484
- DOI: 10.1183/13993003.02669-2021
The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm
Conflict of interest statement
Conflict of interest: Sven F. Seys reports personal fees for lectures from Teva and is an employee of Galenus Health. Conflict of interest: Merete B. Long has nothing to disclose.
Comment on
-
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.Eur Respir J. 2022 Feb 17;59(2):2100142. doi: 10.1183/13993003.00142-2021. Print 2022 Feb. Eur Respir J. 2022. PMID: 34737220 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical